authors
- Crowther, Mark
- Levy, Gallia G
- Lu, Genmin
- Leeds, Janet
- Barron, Lee
- Conley, Pamela B
- Castillo, Janice
- Curnutte, John T
- Connolly, Stuart
ANNEXA (TM)-A: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial, Demonstrating Reversal of Apixaban-Induced Anticoagulation in Older Subjects by Andexanet alfa (PRT064445), a Universal Antidote for Factor Xa (fXa) Inhibitors
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- December 2, 2014
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Cardiovascular System & Hematology (Science Metrix)
published in
- Circulation Journal